Ani Pharmaceuticals Inc (ANIP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.45% 247.06	227.81	211.37	197.12	190.57
Operating Expenses	10.82% 212.29	191.57	197.48	170.93	194.95
Benefits Costs and Expenses	11.12% 215.58	194.01	200.85	177.13	204.34
Costs And Expenses	10.82% 212.29	191.57	197.48	170.93	194.95
Depreciation and Amortization	0.08% 22.61	22.63	23.28	22.89	22.60
Operating Income/Loss	4.06% 34.77	36.24	13.89	26.19	-4.378
Interest And Devidend Income	0.23% 3.544	3.552	2.784	2.623	-
Income/Loss From Continuing Operations Before Tax	6.87% 31.48	33.80	10.53	19.99	-13.76
Income Tax Expense/Benefit	44.47% 3.989	7.183	1.976	4.306	-3.486
Income/Loss From Continuing Operations After Tax	3.28% 27.49	26.62	8.549	15.68	-10.28
Net Income/Loss	3.28% 27.49	26.62	8.549	15.68	-10.28
Preferred Stock Dividends And Other Adjustments	100.00% -	0.344	0.407	0.406	0.406
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.94% 0.213	20.07	19.83	19.61	0.043
Diluted Average Shares	98.50% 0.317	21.09	20.31	20.05	0.043
Basic Earnings Per Share	4.20% 1.24	1.19	0.37	0.70	-0.55
Diluted Earnings Per Share	3.54% 1.17	1.13	0.36	0.69	-0.55
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	15.30% 2.103	2.483	0.819	1.564	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	25.61% 2.103	2.827	1.226	1.97	0.406

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%